Accessibility settings

This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (5386) Web-based and Mobile Health Interventions (5959) Cost-Effectiveness and Economics (519) mHealth for Wellness, Behavior Change and Prevention (4336) Obesity and Nutrition as Public Health Problem (606) Innovations and Technology for Healthy Eating Education (564)

Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/81912, first published .
Plus-size woman in sports bra and leggings checks phone, surrounded by houseplants.

Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study

Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study

Authors of this article:

Rebecca Richards1 Author Orcid Image ;   William Lunt1 Author Orcid Image ;   Michael Whitman1 Author Orcid Image ;   Giulia Spaltro1 Author Orcid Image ;   Rachel Hall1 Author Orcid Image
Article Authors Cited by (9) Tweetations Metrics

Journals

  1. Zufry H, Hariyanto T. Head-to-head comparison of tirzepatide and semaglutide for weight loss: A systematic review and meta-analysis. Obesity Research & Clinical Practice 2026;20(2):92 View
  2. Patel H, Babli S, Shah S, Khambholja S, Lingadahalli T, Villarson C, Rizwanullah U, Kumarsivarajah S, Masood A, Rahming N, Drum Christie S, Wallace L, Alamu O. Post-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis. Cureus 2026 View
  3. Krupski A, Marusza M, Stielow V, Zatyka A. DIGITAL TECHNOLOGIES FOR ADULT OBESITY TREATMENT IN THE GLP-1 ERA: A STRUCTURED REVIEW OF EFFECTIVENESS, ADHERENCE, EQUITY, AND HEALTH-SYSTEM INTEGRATION. International Journal of Innovative Technologies in Social Science 2026;4(2(50)) View
  4. Pérez-Pevida B, Santana Santana M, Liaño Arriola C, Maldonado A, Clérigo B, Ruiz C, Higueruela C, Ballesteros-Pomar M, Bretón Lesmes I, Moreira Rodríguez M. Real-world evaluation of the effectiveness and safety of tirzepatide in patients with obesity: A prospective study. Clinical Nutrition ESPEN 2026;75:105005 View
  5. Wu T, Cai W, Li Z. From explainability to clinical actionability: translating artificial intelligence models into decision support for endocrine disease management. Frontiers in Endocrinology 2026;17 View
  6. Paccola G, de Oliveira R, Mochetti M, Razera F, Vecchi R, Montanher R. Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Head‐to‐Head Studies. Clinical Obesity 2026;16(5) View
  7. Al-Marwani S, Murang Z, Tuah N. Integration technology into health care: a scoping review of digital interventions for adult obesity management. BMC Public Health 2026;26(1) View
  8. Badawoud A, Zaafar D, Alrasheed H, AlDossary K, Alsharif A, Alsaleh N. Novel Anti-Obesity Drugs: Pharmacokinetics, Pharmacodynamics, and Precision Dosing. Current Pharmacology Reports 2026;12(1) View
  9. Manueli Laos E, Fontaine‐Nicola A, Serafica B, Zhang L, Layden B, Berger R, Orda C, Schlottmann F, Pirzada A, Masrur M. Weight‐Loss Outcomes After Sleeve Gastrectomy Versus Tirzepatide in a Minority Cohort With Severe Obesity: Results From a Propensity Score Matched Cohort. Clinical Obesity 2026;16(6) View